Gilead Sciences
GILD
#131
Rank
โ‚ฌ140.24 B
Marketcap
112,96ย โ‚ฌ
Share price
-0.82%
Change (1 day)
16.63%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): โ‚ฌ9.16 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are โ‚ฌ29.73 Billion. In 2025 the company made an earning of โ‚ฌ8.49 Billion, an increase over its 2024 earnings that were of โ‚ฌ0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ9.16 B7.79%
2025 โ‚ฌ8.49 B1319.86%
2024 โ‚ฌ0.59 B-89.94%
2023 โ‚ฌ5.95 B17.97%
2022 โ‚ฌ5.04 B-29.77%
2021 โ‚ฌ7.18 B395.99%
2020 โ‚ฌ1.44 B-67.66%
2019 โ‚ฌ4.47 B-33.84%
2018 โ‚ฌ6.76 B-42.35%
2017 โ‚ฌ11.73 B-20.87%
2016 โ‚ฌ14.83 B-21.06%
2015 โ‚ฌ18.78 B45.8%
2014 โ‚ฌ12.88 B253.01%
2013 โ‚ฌ3.65 B16.51%
2012 โ‚ฌ3.13 B-1.07%
2011 โ‚ฌ3.16 B-6.71%
2010 โ‚ฌ3.39 B11.75%
2009 โ‚ฌ3.03 B29.5%
2008 โ‚ฌ2.34 B19.11%
2007 โ‚ฌ1.96 B-455.74%
2006 -โ‚ฌ0.56 Billion-154.93%
2005 โ‚ฌ1.00 B76.99%
2004 โ‚ฌ0.56 B-266.16%
2003 -โ‚ฌ0.35 Billion-638.24%
2002 โ‚ฌ63.67 M31.5%
2001 โ‚ฌ48.42 M-242.15%
2000 -โ‚ฌ34.07 Million-40.2%
1999 -โ‚ฌ56.97 Million31.85%
1998 -โ‚ฌ43.21 Million8.73%
1997 -โ‚ฌ39.74 Million27.22%
1996 -โ‚ฌ31.24 Million
1994 -โ‚ฌ29.76 Million26.57%
1993 -โ‚ฌ23.51 Million46.49%
1992 -โ‚ฌ16.05 Million362.5%
1991 -โ‚ฌ3.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.53 B 142.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.18 B-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ5.18 B-44.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ27.00 B 190.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.88 B-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.40 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ1.00 B-89.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.39 B-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.40 B 22.60%๐Ÿ‡บ๐Ÿ‡ธ USA